Assembly of infectious hepatitis C virus particles

Slides:



Advertisements
Similar presentations
THE REPLICATION OF VIRUSES Virology Lecture 2 Three lectures dealing with (1) replication of DNA viruses (2) the culture, growth and recognition of virus.
Advertisements

Lecture 18: Intracellular transport Flint et al., Chapter 12.
Topic 41 4.Structure/Function of the Organelles - Synthesis.
Lecture 6 - Intracellular compartments and transport I.
General Principles De novo initiation: – RNA polymerase – RNA template – The initiating NTP and a second NTP Primer Dependant initiation – Protein primer.
Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)
Endomembrane System Yasir Waheed NUST Center of Virology & Immunolgy National University of Sciences &Technology.
Retroviruses - Retroviridae
Flaviviridae Positive stranded RNA viruses. Flaviviridae Enveloped virions made up of a lipid bilayer with two or more types of envelope (E) glycoproteins.
Domenico Sansonno, Franco Dammacco  The Lancet Infectious Diseases 
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Biogenesis of Nascent High Density Lipoprotein Particles
Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus  Takasuke Fukuhara, Chikako Ono, Francesc Puig-Basagoiti, Yoshiharu.
Valerie Le Sage, Alessandro Cinti, Andrew J. Mouland 
Structural biology of hepatitis C virus
Biogenesis of Nascent High Density Lipoprotein Particles
Hepatitis C Virus NS5A Protein–A Master Regulator?
Objectives To understand the general principles involved in RNA replication discussed in Chapter 6 pages To use the following + stranded RNA viruses.
Volume 31, Issue 2, Pages (August 2009)
Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
Hepatitis C virus infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Tensing Up for Lipid Droplet Formation
Cytoplasmic Viral Replication Complexes
Protein Synthesis and Transport within the Cell
HCV NS5A Inhibitors: The Devil Is in the Details
Influenza A Virus Lures Autophagic Protein LC3 to Budding Sites
Volume 141, Issue 3, Pages (September 2011)
Marius K. Lemberg, Matthew Freeman  Molecular Cell 
Figure 1 HCV life cycle and site of action of DAAs
Hepatitis C Virus NS5A Protein–A Master Regulator?
HCV and the hepatic lipid pathway as a potential treatment target
Hepatitis C Virus Replicons Volume 3 and 4
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Volume 34, Issue 2, Pages (April 2009)
The Rational Design of an AIDS Vaccine
Guido T. Bommer, Ormond A. MacDougald  Cell Metabolism 
David Paul, Vanesa Madan, Ralf Bartenschlager  Cell Host & Microbe 
Meindert Lamers, Ilana Berlin, Jacques Neefjes  Current Biology 
Volume 44, Issue 2, Pages (February 2006)
Hepatitis C virus–cell interactions and their role in pathogenesis
Domain-Driven Morphogenesis of Cellular Membranes
Lipid droplets Current Biology
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Protein interactions during the flavivirus life cycle elucidated by MS-based proteomics. Protein interactions during the flavivirus life cycle elucidated.
Interferon-Free Treatment Regimens for Hepatitis C: Are We There Yet?
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
New therapies on the horizon for hepatitis C
Importing Mitochondrial Proteins: Machineries and Mechanisms
New insights into lipid metabolism in the nephrotic syndrome
Taro Kawai, Shizuo Akira  Immunity  Volume 34, Issue 5, Pages (May 2011)
Volume 89, Issue 4, Pages (May 1997)
Protein Translocons Cell
Open Questions in Lipid Droplet Biology
Lost in Translation: An Antiviral Plant Defense Mechanism Revealed
A Flip Turn for Membrane Protein Insertion
Jean Dubuisson, François-Loïc Cosset  Journal of Hepatology 
Membrane Protein Chaperones: A New Twist in the Tail?
Anti−Hepatitis C Virus Drugs in Development
Simplified overview of the HCV life cycle and sites of direct acting antiviral therapies. Simplified overview of the HCV life cycle and sites of direct.
Volume 57, Issue 3, Pages (March 2000)
The Dynamic Nature of the Nuclear Envelope
Marius K. Lemberg, Matthew Freeman  Molecular Cell 
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Jean-Claude Martinou, Richard J. Youle  Developmental Cell 
Understanding How Hepatitis C Virus Builds Its Unctuous Home
Schematic representation of the biogenesis of RV replication complexes
Production and Biomedical Application of Flavivirus-like Particles
Exosomes and Ectosomes in Intercellular Communication
Presentation transcript:

Assembly of infectious hepatitis C virus particles Ralf Bartenschlager, Francois Penin, Volker Lohmann, Patrice André  Trends in Microbiology  Volume 19, Issue 2, Pages 95-103 (February 2011) DOI: 10.1016/j.tim.2010.11.005 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 HCV genome structure and functions of viral proteins. Individual proteins within the polyprotein and their functions in the viral replication cycle are given. Proteases involved in polyprotein processing and cleavage sites are indicated in the top. The 5′ and 3′ NTRs are shown according to secondary structure predictions. For clarity, core protein derivatives generated by internal translation initiation or ribosomal frame shift are not shown ([88] and references cited therein). Abbreviations: SPP, signal peptide peptidase; SP, signal peptidase; cys., cysteine; membr., membranous. Trends in Microbiology 2011 19, 95-103DOI: (10.1016/j.tim.2010.11.005) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Models of HCV assembly. The biogenesis of cytosolic LDs (cLDs) is thought to take place at distinct domains of the rER with the formation of an intra-ER membrane lens of apolar lipids that finally buds off towards the cytosol. (a) Continuity between ER membrane and cLDs should allow their ‘loading’ with core from the ER membrane (1). cLDs might associate with microtubule motors (MTs) and migrate to a specialized smooth ER (sER)-derived membranous web compartment. There, core-loaded cLDs might attach to the ER membrane via tethering proteins (e.g. Rab 18) at sites where luminal (lu) LDs form and in close proximity of ER-bound replicase (2). Nucleocapsid formation might occur by transfer of the RNA from the ER-resident replicase or (as shown here) from oligomeric complexes of NS5A [89] to the core protein that is released back from the cLD to the ER membrane. We suggest that the interface between cLDs and the ER membrane provides a site favoring the translocation of the hydrophobic core proteins to luLDs that are budding into the ER lumen. (b) In this model, cLDs are loaded with core and NS5A (1). ER-bound replication complexes could deliver HCV RNA to NS5A that can freely move onto cLDs, thus forming an NS5A–RNA array. As in the previous model, these cLDs could associate with MTs and move to specialized ER sites (2). Tethering factors might trap cLDs at the ER membrane where viral RNA is transferred from NS5A to core, thus triggering nucleocapsid formation. This step is linked to the delivery of the nucleocapsid into luLDs. It is also possible that nucleocapsids assemble and bud into cLDs at an early step prior to delivery to luLDs (not shown). Both models postulate that the hydrophobic core protein is pulled out of the cLD phospholipid monolayer and inserted into an ER membrane limiting lens of apolar lipids corresponding to nascent luLDs. This process would not require bending of membrane bilayer and thus only limited energy. Trends in Microbiology 2011 19, 95-103DOI: (10.1016/j.tim.2010.11.005) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 3 Models of structures of infectious HCV particles and their biogenesis. During translation at the rER, nascent apoB (blue line) is translocated into the ER lumen and loaded by MTP with phospholipids and triglycerides (left panel). This leads to the formation of a neutral lipid core that is converted into a spherical particle (VLDL2) acquiring exchangeable apoE and apoC (not shown for clarity). In the smooth ER (sER) or membranous web (m.w.), a second precursor (the luminal LD; luLD) is formed from the ER membrane and by MTP-mediated triglyceride enrichment (right panel). E1 and E2 retained at the ER membrane might slide onto this luLD prior to pinching-off [49]. The nucleocapsid would be inserted into the hydrophobic lipid core of the pinching-off luLD due to the hydrophobic nucleocapsid surface (formed by D2 of the core protein). In VLDL competent cells such as primary human hepatocytes, this precursor could fuse with VLDL2 to form the LVP. Alternatively in Huh-7 cells where VLDL1 formation is inefficient [49]. HCVcc is secreted predominantly as particles lacking apoB. Trends in Microbiology 2011 19, 95-103DOI: (10.1016/j.tim.2010.11.005) Copyright © 2010 Elsevier Ltd Terms and Conditions